Human Pim-I Gene

Nagarajan, Lalitha

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 3R29CA049765-04S1
• Application #: 3459422
• Study Section: Mammalian Genetics Study Section (MGN)
• Project Start: 1988-09-01
• Project End: 1993-08-31
• Budget Start: 1991-09-01
• Budget End: 1992-08-31
• Support Year: 4
• Fiscal Year: 1992

Institution

• Name: University of Texas MD Anderson Cancer Center
• Type: Other Domestic Higher Education
• DUNS #: 001910777
• City: Houston
• State: TX
• Country: United States
• Zip Code: 77030

Publications

Chang, Richard L; Wood, Alexander W; Huang, Mou Tuan et al. (2013) Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene. Carcinogenesis 34:2184-91

Nagarajan, L; Narayana, L (1993) Transcriptional attenuation of PIM-1 gene. Biochem Biophys Res Commun 190:435-9

Padma, R; Nagarajan, L (1991) The human PIM-1 gene product is a protein serine kinase. Cancer Res 51:2486-9